HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer - Concepedia

Concepedia

Publication | Open Access

HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer

DOI Full Paper Access

20

Citations

32

References

2022

Year

François Cherifi, Angélique Da Silva, Alison Johnson, Cécile Blanc‐Fournier, Olivia Abramovici, Antonin Broyelle, Christelle Lévy, Djelila Allouache, Ioana Hrab, Carine Ségura,

References

	Year	Citations

Page 1